BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 33422657)

  • 21. Identification of Key Biomarkers and Potential Molecular Mechanisms in Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
    Yang B; Dong K; Guo P; Guo P; Jie G; Zhang G; Li T
    J Comput Biol; 2020 Jan; 27(1):40-54. PubMed ID: 31424263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research on the mechanisms of taraxerol for the treatment of gastric cancer effect based on network pharmacology.
    Huo B; Song Y; Tan B; Li J; Zhang J; Zhang F; Chang L
    Int J Immunopathol Pharmacol; 2022; 36():20587384211063962. PubMed ID: 34986036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor mechanism of kangliu pill on gliomas in mice through PI3K-Akt signaling pathway.
    Chen F; Cui JJ; Jiang DC; Wang HZ; Zhuang W; Feng YN; Lin XL; Xi SY
    J Ethnopharmacol; 2023 May; 307():116252. PubMed ID: 36775078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating network pharmacology and experimental evidence to decipher the cardioprotective mechanism of Yiqihuoxue decoction in rats after myocardial infarction.
    Li FH; Guo SW; Zhan TW; Mo HR; Chen X; Wang H; Wei LL; Feng PF; Wu JG; Li P
    J Ethnopharmacol; 2021 Oct; 279():114062. PubMed ID: 33771641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elucidation of the anti-gastric cancer mechanism of Guiqi Baizhu Formula by integrative approach of chemical bioinformatics.
    Wang Y; Li J; Liu X; Zhang Y; Wang C; Guo Q; Wang Y; Jiang B; Jin X; Liu Y
    Int Immunopharmacol; 2024 Jun; 134():112245. PubMed ID: 38749334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
    Cheng C; Qin Y; Zhi Q; Wang J; Qin C
    Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Analysis of a circRNA-miRNA-mRNA Network to Reveal Potential Inflammation-Related Targets for Gastric Adenocarcinoma.
    Liu Y; Xu Y; Xiao F; Zhang J; Wang Y; Yao Y; Yang J
    Mediators Inflamm; 2020; 2020():9435608. PubMed ID: 32801999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of potential bioactive compounds and mechanisms of GegenQinlian decoction on improving insulin resistance in adipose, liver, and muscle tissue by integrating system pharmacology and bioinformatics analysis.
    Cao Z; Zeng Z; Wang B; Liu C; Liu C; Wang Z; Li S
    J Ethnopharmacol; 2021 Jan; 264():113289. PubMed ID: 32846191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. To study the mechanism of Cuscuta chinensis Lam. And Lycium barbarum L. in the treatment of asthenospermia based on network pharmacology.
    Wang J; Bao B; Meng F; Deng S; Dai H; Feng J; Li H; Wang B
    J Ethnopharmacol; 2021 Apr; 270():113790. PubMed ID: 33460759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioinformatic Analysis of GLI1 and Related Signaling Pathways in Chemosensitivity of Gastric Cancer.
    Yu T; Jia W; An Q; Cao X; Xiao G
    Med Sci Monit; 2018 Mar; 24():1847-1855. PubMed ID: 29596399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Key Genes in Gastric Cancer by Bioinformatics Analysis.
    Chong X; Peng R; Sun Y; Zhang L; Zhang Z
    Biomed Res Int; 2020; 2020():7658230. PubMed ID: 33015179
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systematic Elucidation of the Mechanism of Quercetin against Gastric Cancer via Network Pharmacology Approach.
    Yang L; Hu Z; Zhu J; Liang Q; Zhou H; Li J; Fan X; Zhao Z; Pan H; Fei B
    Biomed Res Int; 2020; 2020():3860213. PubMed ID: 32964029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic and prognostic value of
    Wang MQ; Yin QY; Chen YR; Zhu SL
    Future Oncol; 2021 Dec; 17(35):4907-4923. PubMed ID: 34751593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of hub genes specific to pulmonary metastasis in osteosarcoma through integrated bioinformatics analysis.
    Chai Y; Xu L; He R; Zhong L; Wang Y
    Technol Health Care; 2022; 30(3):735-745. PubMed ID: 34542049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Aloin Against Gastric Cancer.
    Gao J; Yang S; Xie G; Pan J; Zhu F
    Drug Des Devel Ther; 2022; 16():1947-1961. PubMed ID: 35757520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poor expression of microRNA-135b results in the inhibition of cisplatin resistance and proliferation and induces the apoptosis of gastric cancer cells through MST1-mediated MAPK signaling pathway.
    Zhou J; Chen Q
    FASEB J; 2019 Mar; 33(3):3420-3436. PubMed ID: 30576232
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of key genes and pathways involved in trastuzumab-resistant gastric cancer.
    Yu C; Xue P; Zhang L; Pan R; Cai Z; He Z; Sun J; Zheng M
    World J Surg Oncol; 2018 Aug; 16(1):174. PubMed ID: 30134903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Research on the Potential Mechanism of Gentiopicroside Against Gastric Cancer Based on Network Pharmacology.
    Huang Y; Lin J; Yi W; Liu Q; Cao L; Yan Y; Fu A; Huang T; Lyu Y; Huang Q; Wang J
    Drug Des Devel Ther; 2020; 14():5109-5118. PubMed ID: 33262572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.